Jasper Therapeutics director Christian Nolet resigns; Svetlana Lucas joins audit committee

Jasper Therapeutics, Inc.

Christian Nolet resigned from Board and all committees effective May 15, 2026.
Resignation not due to any disagreement with the company's operations, policies or practices.
Board appointed Svetlana Lucas, Ph.D. to the Audit Committee.
No other changes to board composition or officer roles disclosed.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Christian Nolet

Director

JSPR · Jasper Therapeutics, Inc.

Effective: 2026-05-15
Filed: May 21, 2026, 4:01 PM ET

On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christian Nolet resigned as Director at Jasper Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.

View on SEC.gov

Jasper Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-060029

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.